Auxilius Pharma
Pharma start-up with a focus on optimizing and further developing well-established medications
Pharma start-up with a focus on optimizing and further developing well-established medications
Auxilius Pharma is a biotechnology, life sciences, and pharmaceutical startup established in 2019. The company's slogan emphasizes its focus on optimizing and further developing well-established medications to improve patient outcomes. The core mission of Auxilius Pharma is to enhance the lives of patients by providing access to effective and verified pharmaceutical treatments in convenient dosage forms. In November 2022, the company secured a significant milestone with a $1.00M Seed Round investment led by CofounderZone and AUGEBIT FIZ. This investment reflects the confidence of notable players in the startup ecosystem in Auxilius Pharma's vision and potential for growth.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $1.00M | 2 |
|
04 Nov 2022 |
| Pre Seed Round | $250.00K | - | 31 Dec 2021 | |
| Pre Seed Round | $900.00K | 1 | Undisclosed Individual investors | 28 Jul 2021 |
| Pre Seed Round | $100.00K | - | 20 Jan 2020 |
No recent news or press coverage available for Auxilius Pharma.
We care about your data, and we'd love to use cookies make your experience better.
